Tzuling Cheng
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Protein Degradation and Inhibitors 2
- Epigenetics and DNA Methylation 2
- Mitochondrial Function and Pathology 2
- DNA Repair Mechanisms 1
- Glycosylation and Glycoproteins Research 1
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Ralph J. DeBerardinis (4 shared papers)Andrew R. Mullen (2 shared papers)Eunsook S. Jin (2 shared papers)Michael A. White (4 shared papers)Pei-Hsuan Chen (1 shared paper)Youfeng Yang (1 shared paper)W. Marston Linehan (1 shared paper)Lucas B. Sullivan (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Cell (2 papers)British Journal of Clinical Pharmacology (1 paper)Journal of Molecular Medicine (1 paper)Oncogene (1 paper)
- Partner nations
- United StatesTaiwanSpain
In The Last Decade
Tzuling Cheng
15 papers receiving 4.4k citations
Tzuling Cheng's Hit Papers
Peers
Comparison fields: 5 of 110
- Geriatrics and Gerontology 442
- Cancer Research 1.9k
- Molecular Biology 3.0k
- Biochemistry 306
- Oncology 565
Countries citing papers authored by Tzuling Cheng
This map shows the geographic impact of Tzuling Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tzuling Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tzuling Cheng more than expected).
Fields of papers citing papers by Tzuling Cheng
This network shows the impact of papers produced by Tzuling Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tzuling Cheng. The network helps show where Tzuling Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Tzuling Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey Hit paper breakdown → | 2006 | 1284 |
| 2 | Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer Hit paper breakdown → | 2009 | 1087 |
| 3 | Reductive carboxylation supports growth in tumour cells with defective mitochondria Hit paper breakdown → | 2011 | 1062 |
| 4 | 2011 | 394 | |
| 5 | 2011 | 267 | |
| 6 | 2011 | 177 | |
| 7 | 2013 | 81 | |
| 8 | 2004 | 54 | |
| 9 | 2010 | 27 | |
| 10 | 2003 | 22 | |
| 11 | 2018 | 4 | |
| 12 | 2021 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2025 | 1 |
About Tzuling Cheng
Tzuling Cheng is a scholar working on Molecular Biology, Cancer Research, Biotechnology, Computer Networks and Communications and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Protein Degradation and Inhibitors (2 papers), Epigenetics and DNA Methylation (2 papers), Mitochondrial Function and Pathology (2 papers), Cancer Research and Treatments (2 papers), DNA Repair Mechanisms (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Geriatrics and Gerontology (442 citations), Cancer Research (1.9k citations), Molecular Biology (3.0k citations), Biochemistry (306 citations) and Oncology (565 citations). Tzuling Cheng has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Ralph J. DeBerardinis, Andrew R. Mullen, Eunsook S. Jin, Michael A. White, Pei-Hsuan Chen, Youfeng Yang, W. Marston Linehan, Lucas B. Sullivan, William W. Wheaton and Navdeep S. Chandel. Their work appears in journals such as Cancer Research, Molecular Cell, British Journal of Clinical Pharmacology, Journal of Molecular Medicine and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.